In 2004, America Office of Justice commenced investigating profits tactics bordering the antipsychotic drug risperidone (Risperdal). In 2010, the company joined a whistleblower fit alleging that despite remaining warned from the U.S. Foods and Drug Administration not to market Risperdal as productive and Protected for elderly clients, in whom it ha… Read More